A new immunochemical strategy for triple-negative breast cancer therapy

A new immunochemical strategy for triple-negative breast cancer therapy

Abstract Triple-negative breast cancer (TNBC) is a highly diverse group of malignant neoplasms which tend to have poor outcomes, and the development of new targets and strategies to treat these cancers is sorely needed. Antibody–drug conjugate (ADC) therapy has been shown to be a promising targeted...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chih-Wei Lin, Tianqing Zheng, Geramie Grande, Alex R. Nanna, Christoph Rader, Richard A. Lerner
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/65dfaed7185b4b46a02f81c93c98f21c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares